LIVIVO - Search results -

Search results

Result 1 - 10 of total 14

Search options

Article ; Online: COVID-19 Infection: A Neuropsychiatric Perspective.

Manolis, Theodora A / Apostolopoulos, Evdoxia J / Manolis, Antonis A / Melita, Helen / Manolis, Antonis S

The Journal of neuropsychiatry and clinical neurosciences

2021 Volume 33, Issue 4, Page(s) 266–279

Abstract: ... ranging. In addition to acute neuropsychiatric manifestations, COVID-19 may also produce late ... implemented population-wide vaccination, COVID-19 has created unprecedented turmoil in socioeconomic life ... study of the neuropsychiatric manifestations of SARS-CoV-2 infection are offered. ...

Abstract	As a potentially life-threatening disease with no definitive treatment and without fully implemented population-wide vaccination, COVID-19 has created unprecedented turmoil in socioeconomic life worldwide. In addition to physical signs from the respiratory and many other systems, the SARS-CoV-2 virus produces a broad range of neurological and neuropsychiatric problems, including olfactory and gustatory impairments, encephalopathy and delirium, stroke and neuromuscular complications, stress reactions, and psychoses. Moreover, the psychosocial impact of the pandemic and its indirect effects on neuropsychiatric health in noninfected individuals in the general public and among health care workers are similarly far-ranging. In addition to acute neuropsychiatric manifestations, COVID-19 may also produce late neuropsychiatric sequelae as a function of the psychoneuroimmunological cascade that it provokes. The present article presents a state-of-the-science review of these issues through an integrative review and synthesis of case series, large-cohort studies, and relevant meta-analyses. Heuristics for evaluation and further study of the neuropsychiatric manifestations of SARS-CoV-2 infection are offered.
MeSH term(s)	COVID-19/complications ; COVID-19/diagnosis ; Humans ; Mental Disorders/diagnosis ; Mental Disorders/etiology ; Nervous System Diseases/diagnosis ; Nervous System Diseases/etiology ; Neuropsychiatry/methods
Language	English
Publishing date	2021-07-19
Publishing country	United States
Document type	Journal Article ; Systematic Review
ZDB-ID	1036340-3
ISSN	1545-7222 ; 0895-0172
ISSN (online)	1545-7222
ISSN	0895-0172
DOI	10.1176/appi.neuropsych.20110277
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2633: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Covid long : aspects neurologiques.

Nuber-Champier, Anthony / Voruz, Philippe / Cionca, Alexandre / Jacot De Alcântara, Isabele / Péron, Julie Anne / Assal, Frédéric

Revue medicale suisse

2023 Volume 19, Issue 827, Page(s) 972–974

Abstract: The study of post-COVID-19 symptomatology revealed a first wave of post-acute (persistence ... understood. Moreover, the multi-organ manifestations of post-COVID-19 symptoms remind us of the importance ... while others improved. To our knowledge, these symptoms may persist for up to 1 to 2 years after infection ...

Title translation	Long COVID : neurological aspects.
Abstract	The study of post-COVID-19 symptomatology revealed a first wave of post-acute (persistence of symptoms less than 3 months) neurocognitive symptoms. However, some of these symptoms worsened, while others improved. To our knowledge, these symptoms may persist for up to 1 to 2 years after infection. The intensity, variability and persistence of neurocognitive symptoms may rise the hypotheses of accelerated neurodegenerative processes, as well as neuropsychiatric and/or genetic vulnerabilities that are still poorly understood. Moreover, the multi-organ manifestations of post-COVID-19 symptoms remind us of the importance of promoting an interdisciplinary perspective at both clinical and fundamental levels. Finally, many social and economic issues parallel to the neuropathological consequences remain to be investigated.
MeSH term(s)	Humans ; Post-Acute COVID-19 Syndrome ; COVID-19 ; Interdisciplinary Studies ; Knowledge
Language	French
Publishing date	2023-05-17
Publishing country	Switzerland
Document type	English Abstract ; Journal Article
ZDB-ID	2177010-4
ISSN	1660-9379
ISSN	1660-9379
DOI	10.53738/REVMED.2023.19.827.972
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5998: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.

Schwartz, Robert A / Suskind, Robert M

Epidemiology and infection

2023 Volume 152, Page(s) e34

Abstract: ... post-COVID-19 neuropsychiatric impairment may be the commonly employed, readily available, reasonably ... considering formal clinical trials using azithromycin for patients with post-COVID-19 infection neurological ... The devastating effects of the coronavirus disease (COVID-19) caused ...

Abstract	The devastating effects of the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may not end when the acute illness has terminated. A subset of COVID-19 patients may have symptoms that persist for months. This condition has been described as 'long COVID'. From a historical perspective, it has been recognized that serious long-term neurological sequelae have been associated with RNA viruses such as influenza viruses and coronaviruses. A potential intervention for early post-COVID-19 neuropsychiatric impairment may be the commonly employed, readily available, reasonably priced macrolide antibiotic, azithromycin. We have observed a favourable clinical response with azithromycin in three patients with neurological symptoms associated with long COVID-19. We recommend considering formal clinical trials using azithromycin for patients with post-COVID-19 infection neurological changes including 'COVID fog' or the more severe neurological symptoms that may later develop.
MeSH term(s)	Humans ; Azithromycin/therapeutic use ; SARS-CoV-2 ; COVID-19 ; Post-Acute COVID-19 Syndrome ; COVID-19 Drug Treatment
Chemical Substances	Azithromycin (83905-01-5)
Language	English
Publishing date	2023-12-15
Publishing country	England
Document type	Journal Article
ZDB-ID	632982-2
ISSN	1469-4409 ; 0950-2688
ISSN (online)	1469-4409
ISSN	0950-2688
DOI	10.1017/S0950268823001966
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Un I Zs.271: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Pathophysiology of Post-COVID syndromes: a new perspective.

Batiha, Gaber El-Saber / Al-Kuraishy, Hayder M / Al-Gareeb, Ali I / Welson, Nermeen N

Virology journal

2022 Volume 19, Issue 1, Page(s) 158

Abstract: ... the course of SARS-CoV-2 infection is correlated to COVID-19 severity and the development of PCS ... Most COVID-19 patients recovered with low mortality; however, some patients experienced long-term ... COVID-19 survivors, mainly women, and patients with persistent severe fatigue for 10 weeks after ...

Abstract	Most COVID-19 patients recovered with low mortality; however, some patients experienced long-term symptoms described as "long-COVID" or "Post-COVID syndrome" (PCS). Patients may have persisting symptoms for weeks after acute SARS-CoV-2 infection, including dyspnea, fatigue, myalgia, insomnia, cognitive and olfactory disorders. These symptoms may last for months in some patients. PCS may progress in association with the development of mast cell activation syndrome (MCAS), which is a distinct kind of mast cell activation disorder, characterized by hyper-activation of mast cells with inappropriate and excessive release of chemical mediators. COVID-19 survivors, mainly women, and patients with persistent severe fatigue for 10 weeks after recovery with a history of neuropsychiatric disorders are more prone to develop PCS. High D-dimer levels and blood urea nitrogen were observed to be risk factors associated with pulmonary dysfunction in COVID-19 survivors 3 months post-hospital discharge with the development of PCS. PCS has systemic manifestations that resolve with time with no further complications. However, the final outcomes of PCS are chiefly unknown. Persistence of inflammatory reactions, autoimmune mimicry, and reactivation of pathogens together with host microbiome alterations may contribute to the development of PCS. The deregulated release of inflammatory mediators in MCAS produces extraordinary symptoms in patients with PCS. The development of MCAS during the course of SARS-CoV-2 infection is correlated to COVID-19 severity and the development of PCS. Therefore, MCAS is treated by antihistamines, inhibition of synthesis of mediators, inhibition of mediator release, and inhibition of degranulation of mast cells.
MeSH term(s)	COVID-19/complications ; Fatigue ; Female ; Histamine Antagonists ; Humans ; Inflammation Mediators ; Mastocytosis/diagnosis ; SARS-CoV-2
Chemical Substances	Histamine Antagonists ; Inflammation Mediators
Language	English
Publishing date	2022-10-09
Publishing country	England
Document type	Journal Article ; Review ; Research Support, Non-U.S. Gov't
ZDB-ID	2160640-7
ISSN	1743-422X ; 1743-422X
ISSN (online)	1743-422X
ISSN	1743-422X
DOI	10.1186/s12985-022-01891-2
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective.

Pandi-Perumal, Seithikurippu R / Zaki, Nevin F W / Qasim, Mohammad / Elsayed Morsy, Nesreen / Manzar, Md Dilshad / BaHammam, Ahmed S / Jahrami, Haitham / Ramasubramanian, Chellamuthu / Karthikeyan, Ramanujam / Supasitthumrong, Thitiporn / Moscovitch, Adam / Trakht, Ilya / Gupta, Ravi / Narasimhan, Meera / Partonen, Timo / Reiter, Russel J / Morris, Gerwyn / Berk, Michael / Kennedy, Sidney H /

Stein, Dan J / Stahl, Stephen M / Charney, Dennis S / Seeman, Mary V

Alpha psychiatry

2022 Volume 23, Issue 4, Page(s) 144–154

Abstract: Some research suggests that distress, secondary to isolation and fear following COVID-19 infection ... can negatively affect the long-term more than the COVID-19 infection itself. This narrative review aims ... to provide a global view on the neuropsychiatric consequences of COVID-19 that can be ascribed ...

Abstract	Some research suggests that distress, secondary to isolation and fear following COVID-19 infection, can negatively affect the long-term more than the COVID-19 infection itself. This narrative review aims to provide a global view on the neuropsychiatric consequences of COVID-19 that can be ascribed to several factors, ranging from the direct effect of infection, to the body's responses against the infection, or to the psychological sequelae of social isolation, unemployment, and fear for one's health and livelihood. Current findings show that the more severe the respiratory infection, the more likely are central nervous system (CNS) complications regarding the infection itself. The immune reactions to the infection may result in symptoms similar to chronic fatigue as well as neurocognitive deficits, which last long after the infection is gone. An increase in symptoms of depression, anxiety, and trauma-related stress may also follow upon economic fears and isolation from friends and family. The consequences of the pandemic are not limited to adults; children learning remotely and away from classmates and routine activities may develop adjustment disorders, acute stress disorder, and a variety of manifestations of grief. A summary of case reports suggests that COVID-19-related stress, economic recession, and political unrest increase the risk of suicidal behaviors and acts of violence. However, it is unknown whether manifestations of mental disorders result from social causes or whether CNS complications may be responsible.
Language	English
Publishing date	2022-07-01
Publishing country	Turkey
Document type	Journal Article ; Review
ISSN	2757-8038
ISSN (online)	2757-8038
DOI	10.5152/alphapsychiatry.2022.21783
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Pathophysiology of Post-COVID syndromes: a new perspective

Batiha, Gaber El-Saber / Al-kuraishy, Hayder M. / Al-Gareeb, Ali I. / Welson, Nermeen N.

Virol J. 2022 Dec., v. 19, no. 1 p.158-158

2022

Abstract	Most COVID-19 patients recovered with low mortality; however, some patients experienced long-term symptoms described as “long-COVID” or “Post-COVID syndrome” (PCS). Patients may have persisting symptoms for weeks after acute SARS-CoV-2 infection, including dyspnea, fatigue, myalgia, insomnia, cognitive and olfactory disorders. These symptoms may last for months in some patients. PCS may progress in association with the development of mast cell activation syndrome (MCAS), which is a distinct kind of mast cell activation disorder, characterized by hyper-activation of mast cells with inappropriate and excessive release of chemical mediators. COVID-19 survivors, mainly women, and patients with persistent severe fatigue for 10 weeks after recovery with a history of neuropsychiatric disorders are more prone to develop PCS. High D-dimer levels and blood urea nitrogen were observed to be risk factors associated with pulmonary dysfunction in COVID-19 survivors 3 months post-hospital discharge with the development of PCS. PCS has systemic manifestations that resolve with time with no further complications. However, the final outcomes of PCS are chiefly unknown. Persistence of inflammatory reactions, autoimmune mimicry, and reactivation of pathogens together with host microbiome alterations may contribute to the development of PCS. The deregulated release of inflammatory mediators in MCAS produces extraordinary symptoms in patients with PCS. The development of MCAS during the course of SARS-CoV-2 infection is correlated to COVID-19 severity and the development of PCS. Therefore, MCAS is treated by antihistamines, inhibition of synthesis of mediators, inhibition of mediator release, and inhibition of degranulation of mast cells.
Keywords	COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; blood ; cognition ; dyspnea ; mast cells ; microbiome ; mortality ; pathophysiology ; risk ; sleep disorders ; urea nitrogen
Language	English
Dates of publication	2022-12
Size	p. 158.
Publishing place	BioMed Central
Document type	Article ; Online
Note	Review
ZDB-ID	2160640-7
ISSN	1743-422X
ISSN	1743-422X
DOI	10.1186/s12985-022-01891-2
Database	NAL-Catalogue (AGRICOLA)

Order via subito

Article ; Online: Neuronal and Non-Neuronal GABA in COVID-19

Adonis Sfera / Karina G. Thomas / Sarvin Sasannia / Jonathan J. Anton / Christina V. Andronescu / Michael Garcia / Dan O. Sfera / Michael A. Cummings / Zisis Kozlakidis

Reports, Vol 5, Iss 22, p

Relevance for Psychiatry

2022 Volume 22

Abstract: Infection with SARS-CoV-2, the causative agent of the COVID-19 pandemic, originated in China and ... to the high comorbidity of neuropsychiatric illness with gut dysbiosis and endothelial and metabolic ... dysfunctions. In this perspective article, we take a closer look at the pathology emerging from the viral ...

Abstract	Infection with SARS-CoV-2, the causative agent of the COVID-19 pandemic, originated in China and quickly spread across the globe. Despite tremendous economic and healthcare devastation, research on this virus has contributed to a better understanding of numerous molecular pathways, including those involving γ-aminobutyric acid (GABA), that will positively impact medical science, including neuropsychiatry, in the post-pandemic era. SARS-CoV-2 primarily enters the host cells through the renin–angiotensin system’s component named angiotensin-converting enzyme-2 (ACE-2). Among its many functions, this protein upregulates GABA, protecting not only the central nervous system but also the endothelia, the pancreas, and the gut microbiota. SARS-CoV-2 binding to ACE-2 usurps the neuronal and non-neuronal GABAergic systems, contributing to the high comorbidity of neuropsychiatric illness with gut dysbiosis and endothelial and metabolic dysfunctions. In this perspective article, we take a closer look at the pathology emerging from the viral hijacking of non-neuronal GABA and summarize potential interventions for restoring these systems.
Keywords	GABA ; SARS-CoV-2 ; renin–angiotensin system ; microbiome ; neuropsychiatric disorders ; Medicine (General) ; R5-920 ; Medical physics. Medical radiology. Nuclear medicine ; R895-920
Subject code	570
Language	English
Publishing date	2022-06-01T00:00:00Z
Publisher	MDPI AG
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Long-COVID in children: An exploratory case-control study from a bio-psycho-social perspective.

Freda, Maria Francesca / Scandurra, Cristiano / Auriemma, Ersilia / Guarino, Alfredo / Lemmo, Daniela / Martino, Maria Luisa / Nunziata, Francesco / Maldonato, Nelson Mauro / Continisio, Grazia Isabella

Journal of psychosomatic research

2023 Volume 176, Page(s) 111564

Abstract: ... previously had COVID-19 but did not develop LCS) from a bio-psycho-social and psychosomatic perspective ... Syndrome (LCS) and two control groups (i.e., children who did not have COVID-19 and children who had ... of children who had contracted SARS-CoV-2 and 94 were mothers of children who had previously had COVID-19 ...

Abstract	Objective: This study aimed to determine psychosocial differences between children with Long-COVID Syndrome (LCS) and two control groups (i.e., children who did not have COVID-19 and children who had previously had COVID-19 but did not develop LCS) from a bio-psycho-social and psychosomatic perspective. To classify children in these three groups, we examined the percentage of children meeting criteria for LCS, the type, frequency, perceived severity of symptoms, and their prevalence compared with children who never had SARS-CoV-2 infection. Methods: Data were collected from 198 Italian mothers of children aged 4 to 13 years using a cross-sectional web-based case-control survey. Of these, 105 were mothers of children who had contracted SARS-CoV-2 and 94 were mothers of children who had previously had COVID-19. Information was collected on the type and frequency of symptoms commonly referred to as "Long-COVID symptoms" and psychosocial dimensions (i.e., maternal and child health anxiety, COVID-19 anxiety, adjustment, and child deprivation). Descriptive analyses, chi-square tests, Student's T-Test, and analyses of variance were performed. Results: 29 children (15% of the total sample) developed LCS, mostly in the neurological/neuropsychiatric domain (59%), and of mild intensity. Regarding psychosocial and psychological dimensions, maternal health anxiety, child deprivation, and fear of SARS-CoV-2 infection differed between groups, with the first two dimensions higher in children with LCS than in controls and the latter lower in children with LCS than in controls. Conclusion: This study sheds light on the need of integrating a psychosocial approach into the medical care of children with LCS and their caregivers.
MeSH term(s)	Child ; Female ; Humans ; COVID-19 ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome ; Case-Control Studies ; Cross-Sectional Studies
Language	English
Publishing date	2023-12-13
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	80166-5
ISSN	1879-1360 ; 0022-3999
ISSN (online)	1879-1360
ISSN	0022-3999
DOI	10.1016/j.jpsychores.2023.111564
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ui I Zs.233: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Psychoneuroimmunology Aspects of COVID-19 Pandemic

Yuliana, Yuliana

JOURNAL OF CLINICAL MEDICINE; Vol 7 No 1A (2020): Med Hosp; Agustus 2020, Edisi Khusus Covid-19; 226-230 ; Medica Hospitalia : Journal of Clinical Medicine; Vol 7 No 1A (2020): Med Hosp; Agustus 2020, Edisi Khusus Covid-19; 226-230 ; 2685-7898 ; 2301-4369 ; 10.36408/mhjcm.v7i1A

2020

Abstract: ... referred to as Coronavirus disease (COVID-19). COVID-19 disease is a viral infection caused by SARS-CoV-2 ... psychoneuroimmunology aspects of COVID-19 infection in those variable symptoms. DISCUSSION: Neurological symptoms ... will aid in promoting post-pandemic public mental health in order to handle COVID-19 properly and minimize ...

Abstract	BACKGROUND: In December 2019 the world was struck by an outbreak of a disease in China which is now referred to as Coronavirus disease (COVID-19). COVID-19 disease is a viral infection caused by SARS-CoV-2. This disease has spread very quickly throughout the world, causing significant social and economic impacts. Now this incident is called a pandemic. There are many controversial theories up till now, especially about psychoneuroimmunology aspects. Symptoms caused by this disease vary greatly from the main attack of the respiratory system to neuro immunity system. Immune response is the key factor to invasion of this virus into the human body. OBJECTIVE: The aim of this paper is providing comprehensive understanding regarding psychoneuroimmunology aspects of COVID-19 infection in those variable symptoms. DISCUSSION: Neurological symptoms might start from anosmia, loss of taste (ageusia), delirium, encephalitis, Guillain-Barre syndrome, and stroke. Behavior might be affected with specific symptom such as depression and psychosis. Neuropsychiatric sequelae had been found in past viral pandemics. CONCLUSION: Psychoneuroimmunology aspects will determine the variability of symptoms of each patient. Comprehensive understanding of psychoneuroimmunology perspective will aid in promoting post-pandemic public mental health in order to handle COVID-19 properly and minimize socio-economic impacts.
Keywords	covid19
Language	Indonesian
Publishing date	2020-08-28
Publisher	RSUP Dr. Kariadi
Publishing country	id
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: A network perspective on neuropsychiatric and cognitive symptoms of the post-COVID syndrome

Scharfenberg, Daniel / Schild, Ann-Katrin / Warnke, Clemens / Maier, Franziska

Europe's Journal of Psychology

2022 Volume 18, Issue 4, Page(s) 350–356

Abstract: ... of the great variety of neuropsychiatric and cognitive symptoms occurring after COVID-19. We provide ... during acute COVID-19, but develop weeks or months after it. This network perspective shifts the focus ... and months after their acute COVID-19 disease, even when acute symptoms were mild to moderate ...

Title translation	Eine Netzwerkperspektive auf neuropsychiatrische und kognitive Symptome des Post-COVID-Syndroms
Abstract	Many patients that were infected with SARS-CoV-2 experience cognitive and affective symptoms weeks and months after their acute COVID-19 disease, even when acute symptoms were mild to moderate. For these patients, purely neurological explanations are struggling to explain the development and maintenance of the great variety of neuropsychiatric and cognitive symptoms occurring after COVID-19. We provide a psychological perspective based on the network theory of mental disorders as an added explanation that does not displace neurological mechanism but rather complements them. We suggest viewing the SARS-CoV-2 infection as a trigger that first activates nodes in a causally connected network of neuropsychiatric and cognitive symptoms. In the following, activation will spread throughout the network that will get in a self-sustaining stable and dysfunctional state manifesting in ongoing symptoms known as post-COVID-19 syndrome. The network perspective allows to generalize explanations for persistent neuropsychiatric and cognitive symptoms to patients that experienced mild or moderate acute courses of COVID-19, but also to similar phenomena following other viral infections. In addition, it could explain why some symptoms did not occur during acute COVID-19, but develop weeks or months after it. This network perspective shifts the focus from viewing persistent symptoms as a continuation of COVID-19 to acknowledging it as a complex syndrome that indeed originates from the disease but fully unfolds after it (post-COVID). To test the presented network perspective, we will need extensive cross-sectional as well as longitudinal data on cognitive and neuropsychiatric symptoms in post-COVID patients.
Keywords	COVID-19 ; Chronic Illness ; Chronische Krankheit ; Clinical Models ; Folgeschäden ; Klinische Modelle ; Medical Psychology ; Medizinische Psychologie ; Neuropsychiatrie ; Neuropsychiatry ; Sequelae ; Syndrome ; Syndromes
Language	English
Document type	Article
DOI	10.5964/ejop.10097
Database	PSYNDEX

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Inter-library loan at ZB MED